Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target

Nat Genet. 2021 Jan;53(1):9-10. doi: 10.1038/s41588-020-00758-y.

Sanne Bootsma^#^{1

2}, Sanne M van Neerven^#^{1

2}, Louis Vermeulen^{3

4}

¹ Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
² Oncode Institute Amsterdam, Amsterdam, the Netherlands.
³ Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands. l.vermeulen@amsterdamumc.nl.
⁴ Oncode Institute Amsterdam, Amsterdam, the Netherlands. l.vermeulen@amsterdamumc.nl.

^# Contributed equally.

No abstract available

Publication types